With the analysis among 1,401 patents, we discovered top 345 key players by total patent application. GlaxoSmithKline Biologicals SA, Pfizer Inc., Five Prime Therapeutics, Inc. are dominant in this area. They take 8.64% of the total patent filing.
GlaxoSmithKline Biologicals SA
New York, United States
Patent: 33
Five Prime Therapeutics, Inc.
California, United States
Patent: 31
Illinois, United States
Patent: 29
California, United States
Patent: 27
Alkermes Pharma Ireland Ltd.
Idera Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 22
Washington, United States
Patent: 21
New York, United States
Patent: 20
With the analysis among 41 patents, we discovered top 8 start-ups by total patent application. Shenzhen Immvira Pharma Co., Ltd., Institut National de la Santé et de la Recherche Médicale, Veradermics, Inc. are active in this area.
Shenzhen Immvira Pharma Co., Ltd.
Guangdong Sheng, China
Patent: 17
Institut National de la Santé et de la Recherche Médicale
Texas, United States
Patent: 5
Castilla-La Mancha, Spain
Patent: 3
Massachusetts, United States
Patent: 2
New Jersey, United States
Patent: 1
California, United States
Patent: 1
California, United States
Patent: 1
With the analysis among related 453 patents applied in the last 5 years. We discover 147 most active companies in this area. The fast-growing Alkermes Pharma Ireland Ltd., Bristol Myers Squibb Co., IGM Biosciences, Inc. take 11.92% of patent filing during this period.
Alkermes Pharma Ireland Ltd.
New York, United States
Patent: 20
California, United States
Patent: 11
Colorado, United States
Patent: 11
Taiho Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 10
Tokyo-to, Japan
Patent: 10
New York, United States
Patent: 10
Five Prime Therapeutics, Inc.
California, United States
Patent: 10
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 9
Shenzhen Immvira Pharma Co., Ltd.
Guangdong Sheng, China
Patent: 9
With the analysis among related 453 patents in last 5 years, we discover 104 new entrants. Alkermes Pharma Ireland Ltd., Bristol Myers Squibb Co., IGM Biosciences, Inc. are the most active new entrants in this area.
Alkermes Pharma Ireland Ltd.
New York, United States
Patent: 20
California, United States
Patent: 11
Colorado, United States
Patent: 11
Tokyo-to, Japan
Patent: 10
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 9
Universidad Técnica Estatal de Quevedo
undefined undefined
Patent: 8
Georgia, United States
Patent: 8
Centro de Investigaciones Biológicas del Noroeste SC
Baja California Sur, Mexico
Patent: 8
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
With the analysis among 653 patents, we discovered top 86 universities and scientific research institutions by total patent application. University of Mississippi, The University of Southampton, Osaka University are dominant in this area. They take 6.43% of the total patent filing.
University of Mississippi
Mississippi, United States
Patent: 14
The University of Southampton
SOUTHAMPTON, United Kingdom
Patent: 13
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 8
Georgia, United States
Patent: 8
Universidad Técnica Estatal de Quevedo
undefined undefined
Patent: 8
The University of Queensland
Queensland, Australia
Patent: 7
President & Fellows of Harvard College
Massachusetts, United States
Patent: 7
Lombardia, Italy
Patent: 6
Okayama-ken, Japan
Patent: 6